Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Cash: 2012-2025

Historic Change in Cash for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to -$2.6 million.

  • Phibro Animal Health's Change in Cash rose 125.19% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 141.04%. This contributed to the annual value of -$2.6 million for FY2025, which is 108.78% down from last year.
  • As of FY2025, Phibro Animal Health's Change in Cash stood at -$2.6 million, which was down 108.78% from $29.3 million recorded in FY2024.
  • Over the past 5 years, Phibro Animal Health's Change in Cash peaked at $29.3 million during FY2024, and registered a low of -$33.0 million during FY2023.
  • Its 3-year average for Change in Cash is -$2.1 million, with a median of -$2.6 million in 2025.
  • In the last 5 years, Phibro Animal Health's Change in Cash tumbled by 237.16% in 2023 and then surged by 188.97% in 2024.
  • Over the past 5 years, Phibro Animal Health's Change in Cash (Yearly) stood at $13.9 million in 2021, then surged by 73.31% to $24.0 million in 2022, then tumbled by 237.16% to -$33.0 million in 2023, then soared by 188.97% to $29.3 million in 2024, then slumped by 108.78% to -$2.6 million in 2025.